Cargando…

Prostate Cancer Treatment and Work: A Scoping Review

Prostate cancer is the most common malignancy diagnosed in North American men. Although medical advances have improved survival rates, men treated for prostate cancer experience side-effects that can reduce their work capacity, increase financial stress, and affect their career and/or retirement pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu Ko, Wellam F., Oliffe, John L., Bottorff, Joan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734520/
https://www.ncbi.nlm.nih.gov/pubmed/33305678
http://dx.doi.org/10.1177/1557988320979257
_version_ 1783622488131895296
author Yu Ko, Wellam F.
Oliffe, John L.
Bottorff, Joan L.
author_facet Yu Ko, Wellam F.
Oliffe, John L.
Bottorff, Joan L.
author_sort Yu Ko, Wellam F.
collection PubMed
description Prostate cancer is the most common malignancy diagnosed in North American men. Although medical advances have improved survival rates, men treated for prostate cancer experience side-effects that can reduce their work capacity, increase financial stress, and affect their career and/or retirement plans. Working-age males comprise a significant proportion of new prostate cancer diagnoses. It is important, therefore, to understand the connections between prostate cancer and men’s work lives. This scoping review aimed to summarize and disseminate current research evidence about the impact of prostate cancer treatment on men’s work lives. Electronic databases were searched to identify peer-reviewed articles published between 2006 and 2020 that reported on the impact of prostate cancer treatment on men’s work. Following scoping review guidelines, 21 articles that met inclusion criteria were identified and analyzed. Evidence related to the impact of prostate cancer on work was grouped under three themes: (1) work outcomes after prostate cancer treatment; (2) return to work considerations, and (3) impact of prostate cancer treatment on men’s finances. Findings indicate that men’s return to work may be more gradual than expected after prostate cancer treatment. Some men may feel pressured by financial stressors and masculine ideals to resume work. Diverse factors including older age and social benefits appear to play a role in shaping men’s work-related plans after prostate cancer treatment. The findings provide direction for future research and offer clinicians a synthesis of current knowledge about the challenges men face in resuming work in the aftermath of prostate cancer treatment.
format Online
Article
Text
id pubmed-7734520
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-77345202020-12-21 Prostate Cancer Treatment and Work: A Scoping Review Yu Ko, Wellam F. Oliffe, John L. Bottorff, Joan L. Am J Mens Health Prostatic Disorders Prostate cancer is the most common malignancy diagnosed in North American men. Although medical advances have improved survival rates, men treated for prostate cancer experience side-effects that can reduce their work capacity, increase financial stress, and affect their career and/or retirement plans. Working-age males comprise a significant proportion of new prostate cancer diagnoses. It is important, therefore, to understand the connections between prostate cancer and men’s work lives. This scoping review aimed to summarize and disseminate current research evidence about the impact of prostate cancer treatment on men’s work lives. Electronic databases were searched to identify peer-reviewed articles published between 2006 and 2020 that reported on the impact of prostate cancer treatment on men’s work. Following scoping review guidelines, 21 articles that met inclusion criteria were identified and analyzed. Evidence related to the impact of prostate cancer on work was grouped under three themes: (1) work outcomes after prostate cancer treatment; (2) return to work considerations, and (3) impact of prostate cancer treatment on men’s finances. Findings indicate that men’s return to work may be more gradual than expected after prostate cancer treatment. Some men may feel pressured by financial stressors and masculine ideals to resume work. Diverse factors including older age and social benefits appear to play a role in shaping men’s work-related plans after prostate cancer treatment. The findings provide direction for future research and offer clinicians a synthesis of current knowledge about the challenges men face in resuming work in the aftermath of prostate cancer treatment. SAGE Publications 2020-12-11 /pmc/articles/PMC7734520/ /pubmed/33305678 http://dx.doi.org/10.1177/1557988320979257 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Prostatic Disorders
Yu Ko, Wellam F.
Oliffe, John L.
Bottorff, Joan L.
Prostate Cancer Treatment and Work: A Scoping Review
title Prostate Cancer Treatment and Work: A Scoping Review
title_full Prostate Cancer Treatment and Work: A Scoping Review
title_fullStr Prostate Cancer Treatment and Work: A Scoping Review
title_full_unstemmed Prostate Cancer Treatment and Work: A Scoping Review
title_short Prostate Cancer Treatment and Work: A Scoping Review
title_sort prostate cancer treatment and work: a scoping review
topic Prostatic Disorders
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734520/
https://www.ncbi.nlm.nih.gov/pubmed/33305678
http://dx.doi.org/10.1177/1557988320979257
work_keys_str_mv AT yukowellamf prostatecancertreatmentandworkascopingreview
AT oliffejohnl prostatecancertreatmentandworkascopingreview
AT bottorffjoanl prostatecancertreatmentandworkascopingreview